Cortigent, Inc. (CRGT): Kapitalizatsiya va daromad nisbati
Cortigent, Inc. daromadlari klinikalarning maqsadli patent ittifoqlariga va neyroimplantlarning sinov bosqichiga bog'liq. P/S koeffitsiyenti shkalasi ushbu tendentsiyani vizuallashtiradi, esa parametrning joriy holatini aks ettiradi. Brendning neyrostimulyatsiya sohasidagi yuqori maqomi shifokorlarning ishonchini kafolatlaydi, optimallashtirilgan tibbiy logistika esa terapevtik markazlarga uskunalarning uzluksiz yetkazib berilishini ta'minlaydi.
Cortigent, Inc. (CRGT) kompaniyasi koʻrsatkichlari kesimi va tahlili
- joriy kotirovkalar va o'rtacha qiymat prognozi:
- birja kapitallashuvi ma'lumotlari:
- biznesning balans baholash tafsilotlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Umumiy qarzning kapitalga nisbati koeffitsiyenti Cortigent, Inc.|CRGT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi cortigent.com|CRGT - Kompaniyaning jamlangan qarzlari|Qarzning balans qiymatiga nisbati Cortigent Medical|CRGT - Kompaniyaning uzoq muddatli majburiyatlari|Qisqa muddatli qarz hajmi Cortigent|Tezkor likvidlik ko‘rsatkichi cortigent.com
- foyda va bozor koeffitsiyentlari statistikasi:
CRGT - Kompaniyaning sof foydasi|Kutilayotgan sof daromad Cortigent, Inc.|CRGT - P/E multiplikatori|Forvard narx-foyda multiplikatori cortigent.com|CRGT - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati koeffitsiyenti Cortigent Medical|CRGT - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bir aksiya uchun foyda Cortigent|CRGT - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi cortigent.com|CRGT - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Cortigent, Inc.
- sotishdan tushum va biznes daromadlari ko'rsatkichlari:
Kompaniyaning umumiy tahlili:CRGT (Cortigent Inc)
P/S koeffitsiyenti biznesning bozor qiymatini uning yillik daromadiga nisbatan aks ettiradi va bu savdoning har bir dollari uchun to'langan premiumni baholash imkonini beradi. Klinikalar va sug'urta kompaniyalariga yuqori narxli neyral interfeyslarni sotishga bog'liq daromadga ega bo'lgan Cortigent, Inc. (CRGT) uchun P/S multiplikatori grafigi investorlar stimulyatsiya tizimlariga bo'lgan kelajakdagi talabni joriy savdo hajmlari bilan solishtirganda qanchalik optimistik baholashini aniqlashga yordam beradi.
Cortigent, Inc. kimlar bilan raqobatlashadi
BIIB - Sotuvga nisbatan narx|Narxning daromadga nisbati Neurocrine Biosciences, Inc. NBIX|RGC: Kapitalizatsiya va daromad nisbati|AXSM: Kapitalizatsiyaning daromadga nisbati|ACADIA Corp - Kapitalizatsiyaning sotish hajmiga nisbati|XENE (Xenon Pharmaceuticals) - Kapitalizatsiyaning daromadga nisbati|vikingtherapeutics.com - Bozor kapitallashuvining daromadga nisbati|SUPN (Supernus) - P/S multiplikatori|Catalyst Pharma (CPRX) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Denali Therapeutics Inc (DNLI)|Harmony Corp - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BHVN (Biohaven Ltd.)|AMLX - Kapitalizatsiyaning daromadga nisbati|TRVI: Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti Praxis Precision Medicines Inc PRAX|AVXL: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati CeriBell EEG|Narxning daromadga nisbati Prothena Biosciences|ALEC: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ANNX|omeros.com (OMER) - Narx/daromad multiplikatori|Neurogene Corp - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati ACIU (AC Immune Inc)|VYGR - Narxning daromadga nisbati|NMRA (neumoratx.com) - Kapitalizatsiya va daromad nisbati|SCLX: P/S multiplikatori|Sotuvga nisbatan narx Tevogen Bio Holdings Inc. (TVGN)|Kapitalizatsiyaning daromadga nisbati ACOG|P/S multiplikatori Cognition Therapeutics Inc.|Narxning daromadga nisbati Inhibikase Therapeutics (IKT)|SAVA (cassavasciences.com) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Assertio ASRT|Coya Therapeutics Inc (COYA) - Sotuvga nisbatan narx|VistaGen Therapeutics Inc - P/S multiplikatori|Ovid Therapeutics Inc. (OVID) - Kapitalizatsiyaning daromadga nisbati|Acumen Pharmaceuticals (ABOS) - Narxning daromadga nisbati|Sotuvga nisbatan narx cervomed.com (CRVO)|Narxning daromadga nisbati Alterity Therapeutics Ltd.|CLNN: Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati PEPG (PepGen Inc.)|Kapitalizatsiyaning sotish hajmiga nisbati JUNS|P/S multiplikatori RLMD (Relmada Therapeutics)|Narx/daromad koeffitsiyenti annovisbio.com (ANVS)|Grace Tx - P/S multiplikatori|Narx/daromad multiplikatori Firefly Neuroscience, Inc. (AIFF)|KLTO: P/S multiplikatori|Sotuvga nisbatan narx NeuroSense Therapeutics Ltd. (NRSN)|Narxning daromadga nisbati Reviva Pharmaceuticals|Kapitalizatsiya va daromad nisbati MTVA (MetaVia, Inc.)|Kapitalizatsiyaning daromadga nisbati NRXS (NeurAxis)|Kapitalizatsiyaning sotish hajmiga nisbati HSDT|Passage Bio - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati NEUP|Minerva Neurosciences - P/S multiplikatori|Narx/daromad koeffitsiyenti athira.com ATHA|Addex Therapeutics Ltd (ADXN) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati ALZN|CYCN (Cyclerion Therapeutics Inc.) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Protagenic (PTIX)|Kapitalizatsiyaning daromadga nisbati KTTA (Pasithea Therapeutics)|Narx/daromad koeffitsiyenti avenuetx.com|P/S multiplikatori BCLI (BrainStorm Cell Therapeutics)|CARA - Kapitalizatsiyaning daromadga nisbati|CHRO - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ELYM (Eliem Therapeutics)|ITCI: P/S multiplikatori|Narx/daromad multiplikatori longboardpharma.com LBPH|Kapitalizatsiyaning daromadga nisbati MRNS|NKGN (NKGen Biotech Inc) - Kapitalizatsiyaning sotish hajmiga nisbati|Narxning daromadga nisbati NeuroBo (NRBO)|Sage Therapeutics Inc - Kapitalizatsiya va daromad nisbati|P/S multiplikatori SNPX (Synaptogenix, Inc.)|trevena.com (TRVN) - Sotuvga nisbatan narx|VIGL: Kapitalizatsiyaning daromadga nisbati|WENA - P/S multiplikatori|Cerevel (CERE) - Narxning daromadga nisbati
